Efficacy of Sotrovimab (SOT), Molnupiravir (MOL), and Nirmatrelvir/Ritponavir (N/R) and Tolerability of Molnupiravir in Outpatients at High Risk for Severe COVID-19

Objective: The main goal of this study was to assess the potential clinical impact of an outpatient administration of available antivirals including SOT, N/R, and MOL to COVID-19 patients at high risk for disease progression. Methods: We conducted a retrospective analysis on 2606 outpatient individu...

Descripción completa

Detalles Bibliográficos
Autores principales: Kauer, Victoria, Totschnig, David, Waldenberger, Ferdinand, Augustin, Max, Karolyi, Mario, Nägeli, Michelle, Wenisch, Christoph, Zoufaly, Alexander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10224114/
https://www.ncbi.nlm.nih.gov/pubmed/37243267
http://dx.doi.org/10.3390/v15051181

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10224114/
https://www.ncbi.nlm.nih.gov/pubmed/37243267
http://dx.doi.org/10.3390/v15051181

Ejemplares similares